Other featured articles
The Bigger Message Behind Amgen’s Decision to Slash Cost of its Repatha Cholesterol Drug
Drug companies look to haggle less and sell more, and that could cost Express Scripts, CVS Health and UnitedHealth writes Goldman in MarketWatch.
PODCAST: The Healthcare Issues Voters Care About in the 2018 Midterms
Fellow Matthew Fiedler reviews the Trump administration’s changes to the ACA, Medicaid expansion and how often candidates are talking about health policy.
Analyzing Senator Hassan’s Binding Arbitration Approach To Preventing Surprise Medical Bills
Following the introduction of the "No More Surprise Medical Bills Act of 2018," USC-Brookings Schaeffer Initiative for Health Policy experts analyze what the legislation could mean for patients if signed into law.
Proposition 3 Could Provide New Resources for Utahns with Diabetes
An overlooked factor in the debate over Proposition 3 is the impact that an expansion of Utah’s Medicaid program would have on the state’s diabetes epidemic, argues Rebecca Myerson in an op-ed in the Salt Lake Tribune.